Anti-proliferative Effects Curcumin in Human Acute Lymphoblastic leukemia Cell Line

Acute lymphoblastic leukemia (ALL) is one of the most common cancers among children. Although there have been tremendous treatments, none of them have led to a precise cure. The use of herbal medicines which are safe and non-toxic have been demonstrated in this study. Curcumin is a polyphenol, hydrophobic product that is derived from turmeric plant. Curcumin has anti-toxic, anti-bacterial, anti-inflammatory, anti-cancer and anti-apoptosis properties. In recent years, extensive researches have been performed over the use of curcumin on cancers. In this study, CCRF-CEM cell line has been treated by curcumin. Rate of cytotoxicity of curcumin and the viability of the cells after treatment were evaluated by MTT assay and flow cytometry analysis. When different concentrations of curcumin were used upon the CCRF-CEM cell line at different times, it was found that curcumin effect depended on dose and time pattern. The results revealed that curcumin could induce apoptosis in CCRF-CEM cell line of acute lymphoblastic leukemia.

[1]  Aaron Smith,et al.  Multiple Actions of Curcumin Including Anticancer, Anti-Inflammatory, Antimicrobial and Enhancement via Cyclodextrin , 2015 .

[2]  M. Saraswathy,et al.  Different strategies to overcome multidrug resistance in cancer. , 2013, Biotechnology advances.

[3]  Mara C. Ebeling,et al.  Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics. , 2013, Current drug metabolism.

[4]  Murali M. Yallapu,et al.  Curcumin nanomedicine: a road to cancer therapeutics. , 2013, Current pharmaceutical design.

[5]  J. Cortes,et al.  Re-emergence of interferon-α in the treatment of chronic myeloid leukemia , 2012, Leukemia.

[6]  Hongyu Zhou,et al.  The targets of curcumin. , 2011, Current drug targets.

[7]  Chuanbing Shi,et al.  Upregulation of p53 Expression in Patients with Colorectal Cancer by Administration of Curcumin , 2011, Cancer investigation.

[8]  E. Srivatsan,et al.  Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma , 2011, Molecular Cancer.

[9]  G. Dontu,et al.  Targeting breast stem cells with the cancer preventive compounds curcumin and piperine , 2010, Breast Cancer Research and Treatment.

[10]  B. Aggarwal,et al.  Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively? , 2009, The AAPS Journal.

[11]  Serge Eifes,et al.  Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. , 2008, Biochemical pharmacology.

[12]  K. Schulze-Osthoff,et al.  Cancer stem cell markers in common cancers - therapeutic implications. , 2008, Trends in molecular medicine.

[13]  B. Aggarwal.  Prostate cancer and curcumin: Add spice to your life , 2008, Cancer biology & therapy.

[14]  B. Aggarwal,et al.  Curcumin and cancer: an "old-age" disease with an "age-old" solution. , 2008, Cancer letters.

[15]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[16]  B. Aggarwal,et al.  Role of curcumin in cancer therapy. , 2007, Current problems in cancer.

[17]  Qiujuan Li,et al.  The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells. , 2007, Life sciences.

[18]  G. Deng,et al.  Complementary and alternative therapies for cancer. , 2004, The oncologist.

[19]  R. Buttyan,et al.  Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo , 2001, The Prostate.

[20]  A. Shehzad,et al.  Curcumin: Multiple molecular targets mediate multiple pharmacological actions: A review , 2010, Drugs of the Future.